Powered 500 · 2026POWEREDS. 406 of 500
By co-founding Twist Bioscience and pioneering a silicon-based DNA synthesis platform, Emily Leproust built a NASDAQ-listed, multi-hundred-million-dollar enterprise that now supplies synthetic DNA for drug discovery, diagnostics, and data storage to thousands of customers worldwide.
Emily Leproust co-founded Twist Bioscience, a NASDAQ-listed synthetic biology company that pioneered a silicon-based DNA synthesis platform.
Twist's technology serves pharmaceutical, industrial, agricultural, and academic customers, enabling work in drug discovery, diagnostics, and DNA data storage. The company has grown into a multi-hundred-million-dollar revenue enterprise serving thousands of customers.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
